China Biologic Products Holdings Inc operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Biologic Products Holdings Inc with three other
companies in this sector in China:
Shanghai Raas Blood Products Company Limited
sales of 2.33 billion Chinese Renmimbi [US$361.38 million]
of which 97%
was Blood products production and sales),
Tonghua Dongbao Medicines Company Limited
(2.03 billion Chinese Renmimbi [US$315.35 million]
of which 96%
was Pharmaceutical), and
Beijing Tiantan Biologic.
(2.10 billion Chinese Renmimbi [US$325.53 million]
of which 99%
was Biological products industry).
During the year ended December of 2016, sales at
China Biologic Products Holdings Inc were 2.27 billion Chinese Renmimbi (US$352.63 million).
increase of 21.8%
versus 2015, when the company's sales were 1.86 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at China Biologic Products Holdings Inc
(and since 2011, sales have increased a total of 130%).